16th ESMO World Congress on Gastrointestinal Cancer

Oncology Meeting Resources

25 Jun - 28 Jun 2014, Barcelona, Spain

World GI 2013

New findings, new techniques, and recent efforts in research and discovery have changed the way physicians treat their patients - taking a more individualised approach. The 16th ESMO World Congress on Gastrointestinal Cancer provided important clinical updates in the management of patients.

Here, you will find the abstracts, PDF presentation and webcasts from World GI 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Search Meeting Resources by Keyword

Useful links




Format available

http://oncologypro.esmo.org/Meeting-Resourc...of-the-science-and-treatment-recommendations

Date: 25 Jun 2014
Presenter: Powel H. Brown
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...with-locally-advanced-pancreatic-cancer-LAPC

Introduction Pancreatic adenocarcinoma (PDAC) remains an unmet medical need causing ∼ 200,000 deaths / year globally [Bilimoria KY, Cancer 2007; 110:738-44]. Gemcitabine (GEM) remains an acceptable...

Date: 25 Jun 2014
Presenter: J. Evans
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resources/World-GI-2014/Familial-pancreatic-cancer

Date: 25 Jun 2014
Presenter: Margaret Tempero
Resources: Presentation, Webcast
Topics: Familial Cancer, Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-LAPC-an-ancillary-study-of-the-LAP-07-trial

Introduction The management of LAPC patients remains controversial. Better discrimination for Overall Survival (OS) is needed to improve therapeutic decisions. We aimed to address this issue on the...

Date: 25 Jun 2014
Presenter: D. Vernerey
Resources: Abstract
Topic: Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ed-on-or-following-gemcitabine-based-therapy

Introduction MM-398 (nal-IRI) is a novel encapsulation of irinotecan in a long-circulating nanoliposome. MM-398 had clinical activity in a Phase 2 study of pts with metastatic pancreatic adenocarcinoma ...

Date: 25 Jun 2014
Presenter: Daniel Von Hoff
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resourc...metastatic-pancreatic-cancer-the-RECAP-trial

Introduction Local and systemic inflammation are hallmarks of cancer, including pancreatic cancer, that adversely impact prognosis. Given the role of JAK-STAT signaling in cancer inflammation, the...

Date: 25 Jun 2014
Presenter: Herbert Hurwitz
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resourc...atients-with-metastatic-pancreatic-cancer-pc

Introduction High expression of secreted protein acidic and rich in cysteine (SPARC) has been associated with poorer overall survival (OS) in patients with resectable PC (Infante. J Clin Oncol. 2007).

Date: 25 Jun 2014
Presenter: Manuel Hidalgo
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Pancreatic Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...2014/Intraductal-papillary-mucinous-neoplasm

Date: 25 Jun 2014
Presenter: Pascal Hammel
Resources: Presentation, Webcast
Topic: Pancreatic Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ancreatic-cancer-Anything-new-on-the-horizon

Date: 25 Jun 2014
Presenter: Markus Büchler
Resources: Presentation, Webcast
Topics: Pancreatic Cancer, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...r-patients-with-metastatic-pancreatic-cancer

Date: 25 Jun 2014
Presenter: Christophe Louvet
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Pancreatic Cancer